The observed greater severity of dyskinesia in animals with a large number of serotonergic endings in the striatum is not due to DA release per se but rather to an abnormal activation pattern (with a predominance of D1R over D2R) and lack of an adequate DA gradient [100]. Here, DRD1 is linked to drug-induced dyskinesia.